AUG 14, 2026 · PHASE 1 TRIAL
A Study to Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy Adult Japanese Participants With Overweight or Obesity.
ClinicalTrials.gov
Phase 1 safety and tolerability study in healthy volunteers with no results posted; designed to characterize adverse events and pharmacokinetics of a novel agent, not efficacy or clinical benefit.
Reported
Planned enrollment24
Phase1
Primary outcome measureNumber of Participants with Adverse Events…